Home / Stocks / KAPA

KAPA insider trading

Kairos Pharma, LTD. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
3
Bought · 24 mo
$10k
Buys · last 90 days
0 · $0
Most recent buy
2024-11-25

Cluster buy detected

3 insiders bought KAPA within a short window (2024-11-20→2024-11-25), $10k in total — cluster score 55/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2024-11-25Samuelson Dougcluster
Chief Financial Officer
Bought2,500$1.50$4k
2024-11-25Murali Ramachandrancluster
VP of Research and Development
Bought200$1.59$318
2024-11-21Yu John Scluster
CEO and Chairman
Bought4,000$1.44$6k

Most active insider buyers

InsiderRoleBuysTotal bought
Yu John SCEO and Chairman1$6k
Samuelson DougChief Financial Officer1$4k
Murali RamachandranVP of Research and Development1$318

See KAPA on the chart

Every insider buy and sell for KAPA plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.